Taken together, we provide evidence for stress-inducible cell surface relocalization of intracellular PRL3 antigens to demonstrate mechanistic support for PRL3-zumab’s ability to recognize and target PRL3+ tumor cells in vivo. This evidence concerns the gene PTP4A3 and neoplasm.